Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: Nivolumab or brentuximab vedotin with the AVD regimen

Documenti analoghi

• Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
  di: Amber Gibson, et al.
  Pubblicazione: (2024)
• Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy
  di: Ariel Nash, et al.
  Pubblicazione: (2024)
• Venetoclax use in a patient with ataxia telangiectasia and early T‐cell precursor acute lymphoblastic leukemia
  di: Shaikha Alqahtani, et al.
  Pubblicazione: (2024)
• Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post‐Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation
  di: Irtiza N. Sheikh, et al.
  Pubblicazione: (2024)
• KIT ‐mutated pediatric core‐binding factor systemic mastocytosis‐acute myeloid leukemia treated with avapritinib and decitabine
  di: Irtiza N. Sheikh, et al.
  Pubblicazione: (2024)